Latest News about KRYS
Recent news which mentions KRYS
What Will AbbVie Buy Next?
June 28, 2023
From Motley Fool
From Benzinga
FDA Approves First Redosable Gene Therapy, Krystal Biotech's Treatment For Skin Blistering Disorder
May 22, 2023
Tickers
KRYS
From Benzinga
From Benzinga
From Benzinga
Dentsply Sirona, Chico's FAS, Kontoor Brands And Other Big Stocks Moving Higher On Tuesday
February 28, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023
February 28, 2023
From Benzinga
Have A Look At William Blair's Top Biotech Picks For 2023
December 25, 2022
From Benzinga
The 7 Hottest Biotech Stocks to Own in 2023 and Beyond
December 18, 2022
From InvestorPlace
Krystal Biotech Epidermolysis Bullosa Study Data Published In New England Journal Of Medicine
December 15, 2022
Tickers
KRYS
From Benzinga
2 Risky Stocks That Could Soar in 2023
December 06, 2022
From Motley Fool
SolarEdge To Rally 54%? Plus This Analyst Predicts $1,335 For Mettler-Toledo International
November 08, 2022
From Benzinga
From Benzinga
2 Growth Stocks That Could Double in the Next Year
September 19, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
August 25, 2022
From Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 18, 2022
From Benzinga
FDA Accepts Krystal Biotech's Filing For Genetic Skin Disorder Candidate Under Priority Review
August 18, 2022
Tickers
KRYS
From Benzinga
Krystal Biotech, Inc. (KRYS) Comes Up Short on Second Quarter EPS by 9 Cents. KRYS is trading at $83.08
August 08, 2022
Tickers
KRYS
From Best Stocks
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
From Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 01, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.